Quantbot Technologies LP Sells 4,057 Shares of iShares Biotechnology ETF $IBB

Quantbot Technologies LP trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 39.5% in the third quarter, Holdings Channel.com reports. The firm owned 6,203 shares of the financial services provider’s stock after selling 4,057 shares during the period. Quantbot Technologies LP’s holdings in iShares Biotechnology ETF were worth $896,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Citigroup Inc. lifted its position in iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock valued at $515,398,000 after purchasing an additional 865,823 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of iShares Biotechnology ETF by 27.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock valued at $153,039,000 after purchasing an additional 226,852 shares during the last quarter. Bronte Capital Management Pty Ltd. grew its position in shares of iShares Biotechnology ETF by 12.6% during the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock worth $37,000 after buying an additional 32,947 shares during the period. Employees Retirement System of Texas acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $25,049,000. Finally, Thrivent Financial for Lutherans raised its stake in shares of iShares Biotechnology ETF by 5.8% during the third quarter. Thrivent Financial for Lutherans now owns 111,863 shares of the financial services provider’s stock worth $16,149,000 after buying an additional 6,157 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $167.56 on Friday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64. The company’s 50 day simple moving average is $172.68 and its 200 day simple moving average is $161.31.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were paid a $0.1831 dividend. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.